Merck Life Sciences
Corporate VC
MRL Ventures Fund: therapeutics-focused CVC backing early-stage breakthrough therapeutics globally.
Seed
Early Stage
Biotech
Therapeutics
- Headquarters
- Cambridge, United States
- Website
- merck.com
- AUM
- $500.0M
- Last Investment
- Nov 2023
- Geographic Focus
- Global
Investment Thesis
Invest in first-in-class therapeutics across modalities to transform patient care.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account